TH Theratechnologies Inc.

Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies to Announce Second Quarter 2025 Financial Results

MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.

Given the announcement of July 2, 2025, concerning the , a conference call will not be held.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at , on SEDAR+ at  and on EDGAR at . Follow Theratechnologies on  and . 

Contacts:

Investor inquiries:

Philippe Dubuc

Senior Vice President and Chief Financial Officer



1-438-315-6608

Media inquiries:

Julie Schneiderman

Senior Director, Communications & Corporate Affairs



1-514-336-7800



EN
03/07/2025

Underlying

THTheratechnologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Theratechnologies Inc.

 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Announces Independent Proxy Advisor Firms ISS and Gl...

Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak Your vote is important regardless of the number of Shares you own.Board unanimously recommends shareholders vote “FOR” the Arrangement.Shareholders are encouraged to review the circular carefully and submit their proxies in advance of the proxy voting deadline of 10:00 a.m. (Eastern time) on September 10, 2025.Visit  for more information.Questions or require voting assistance? Contact Laurel Hill Advisory Group at 1-877-452-7184 o...

September 2, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies annonce que les agences de conseil en vote indépenda...

Theratechnologies annonce que les agences de conseil en vote indépendantes ISS et Glass Lewis recommandent aux actionnaires de voter « EN FAVEUR » du plan d’arrangement prévu avec Future Pak Votre vote est important, quel que soit le nombre d’actions que vous détenez.Le conseil d’administration recommande à l’unanimité aux actionnaires de voter EN FAVEUR de l’arrangement.Les actionnaires sont invités à lire attentivement la circulaire et à remettre leurs formulaires de procuration avant la date limite de vote par procuration du 10 septembre 2025 à 10 h (heure de l’Est). Pour plus de renseig...

September 2, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Announces Filing of Special Meeting Materials and Re...

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 per share, represents a compelling premium of 216% to the closing price on the Nasdaq on April 10, 2025, the date prior to the announcement of Future Pak’s initial non-binding proposal.Board unanimously recommends shareholders ...

August 18, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies annonce le dépôt des documents relatifs à l’assemblé...

Theratechnologies annonce le dépôt des documents relatifs à l’assemblée extraordinaire et l’obtention d’une ordonnance provisoire concernant son acquisition par CB Biotechnology, un membre du même groupe que Future Pak Les actionnaires pourraient recevoir une prime en espèces considérable et attrayante puisque le prix d’achat de 3,01 $ US, assorti d’un droit conditionnel à la valeur représentant des paiements supplémentaires totaux pouvant atteindre 1,19 $ US par action, constitue une prime intéressante de 216 % par rapport au cours de clôture sur le Nasdaq le 10 avril 2025, veille de l’ann...

August 18, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Reports Financial Results for the Second Quarter 202...

Theratechnologies Reports Financial Results for the Second Quarter 2025 Q2 2025 total revenue of $17.7 million, and $36.8 million for the first six months of Fiscal 2025Positive Adjusted EBITDA1 for the fifth straight quarterSubsequent to quarter end, Theratechnologies entered into a definitive agreement to be acquired by an affiliate of Future Pak MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today reported business highlights and financial results fo...

July 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch